Venus Remedies Limited

Venus Remedies Limited Venus Remedies Limited is a Fully Integrated & R&D-Driven Global Pharmaceutical Company Operations Mr.

We have started with the most common glucose and glucose saline, which were dispensed in 500 ml bottles and administered through plastic IV (intravenous injections) sets. These low technology products were manufactured in our first production unit in Panchkula, which happens to be the company's headquarter till date. Venus had been doing good and making substantial profit over this period by selling its products directly through hospitals for use in ICUs. Until in 1994- 1995, when a decision changed the entire perspective of the company. Pawan Chaudhary, CMD, Venus Remedies Limited decided to expand the product portfolio as the stringent price controls imposed by the Govt. and fierce competition in the market, the price of the intravenous fluids remained almost the same over the past two decades. This had made the company to transform itself by switching from manufacturing 500 ml bottles to liquid injections (vials), eyes and nasal drops (vials) and liquid injections (ampoules). Since then, our research team is proving itself as a power house of innovation by filing many international patents for sophisticated formulations of antibiotics and oncological therapeutics. We are constantly working to broaden the pipeline of products and to make an impact in the global market. Currently, the company has a presence in 5 continents and 60 countries covering more than 75 products, 11 overseas offices and competent staff of more than 1500 employees. It is among the world's 10 leading fixed dosage injectable manufacturers.

28/02/2026

On National Science Day 2026, we celebrate the power of science to change lives.
At VMRC, science is not just pursued; it is powered by purpose. Every study, every collaboration, and every breakthrough reflects our commitment to tackling critical global challenges—especially in the fight against antimicrobial resistance.
As we look ahead, our focus remains clear: advancing evidence-based innovations that make healthcare safer, stronger, and more effective for communities worldwide.

Venus’ Participation in the IAIH Panel DiscussionWe were honored to participate in the 2nd India AMR Innovation Workshop...
27/02/2026

Venus’ Participation in the IAIH Panel Discussion

We were honored to participate in the 2nd India AMR Innovation Workshop held in New Delhi under the aegis of C-CAMP. The workshop brought together leaders from government, global health institutions, industry, and innovation ecosystems to deliberate on strengthening India’s response to antimicrobial resistance (AMR).

Mr. Saransh Chaudhary, CEO of Venus Medicine Research Centre, represented the organization on the panel discussion titled “Pathways for Deployment & Scale of AMR Innovations”. The session focused on enabling sustainable translation of AMR innovations from development to real-world implementation and scaling impact through coordinated stakeholder action.

As a research-driven organization committed to critical-care antibiotics and responsible innovation, VMRC values platforms that foster dialogue across sectors. We thank the organizers and fellow panelists for an engaging discussion and look forward to continued collaboration to strengthen India’s AMR innovation and deployment ecosystem.

Our achievements begin with our people. At Venus Remedies, every recognition badge represents dedication, discipline, an...
26/02/2026

Our achievements begin with our people. At Venus Remedies, every recognition badge represents dedication, discipline, and sustained performance. We celebrate the individuals whose commitment continues to strengthen our collective success.

Their progress reflects the power of consistent growth and team spirit.

👉 News Coverage by - Mr. Vikram Singh, Reporter at Venus Pulse.

25/02/2026

In this edition of Venus Asks, we speak with Ms. Preeti Lal, Senior Executive Officer – Human Resource Acquisition, as she shares insights on strengthening talent acquisition, supporting workforce growth, and building a strong people-first culture at Venus Remedies.

👉 Watch the full conversation in the video.



24/02/2026

Recognizing the individuals who make every milestone meaningful.

Our work anniversaries celebrate the dedication and teamwork of employees who contribute daily to the growth of Venus Remedies and the advancement of healthcare.

Thank you for being an integral part of the Venus Remedies journey and growing with us year after year.

News coverage by Mr. Vikram Singh, Reporter at Venus Pulse.


Artificial Intelligence is reshaping the future of oncology.AI supports earlier detection, improves imaging insights, an...
23/02/2026

Artificial Intelligence is reshaping the future of oncology.
AI supports earlier detection, improves imaging insights, and accelerates drug research in cancer care. It is becoming a strong assistive tool, helping bring greater precision to treatment decisions. 

But, technology must be used responsibly. Clinical validation, strong data quality, and careful integration remain essential.

At Venus Remedies, we believe innovation should support medical expertise and always keep patient safety at the center.

At Venus Remedies, we deeply value the dedicated individuals who work behind the scenes to ensure our workplace function...
21/02/2026

At Venus Remedies, we deeply value the dedicated individuals who work behind the scenes to ensure our workplace functions smoothly our support staff. Through our continued initiatives, we acknowledge and appreciate our housekeeping, hospitality, and transport teams, whose consistent efforts help maintain a safe, organized, and welcoming environment for all. By extending recognition and meaningful support, we reinforce our commitment to dignity, respect, and unity as the foundation of a strong workplace culture.

News Coverage by - Ms. Priyanka, Reporter at Venus Pulse.

Venus Remedies marks another global milestone as VRL Unit I & II receive regulatory approval from the Gabon Authority. T...
20/02/2026

Venus Remedies marks another global milestone as VRL Unit I & II receive regulatory approval from the Gabon Authority. This achievement reflects our continued focus on quality standards, regulatory compliance, and expanding access to reliable healthcare solutions across international markets. We remain committed to strengthening our global presence through responsible and compliant manufacturing practices.

News Coverage by - Mr. Saurabh from(CQRA Department Baddi Unit II) Reporter at Venus Pulse.

At Venus Remedies, HR Connect brings teams together to listen, engage, and grow. These moments of interaction with the H...
19/02/2026

At Venus Remedies, HR Connect brings teams together to listen, engage, and grow. These moments of interaction with the HR team help us build a supportive environment where every voice matters and every contribution is valued.

News Coverage by - Vikram Singh, Reporter at Venus Pulse.

India has introduced regulatory norms for AI-based cancer detection tools, placing them under CDSCO oversight and Class ...
18/02/2026

India has introduced regulatory norms for AI-based cancer detection tools, placing them under CDSCO oversight and Class C medical device classification. These measures emphasize scientific validation, safety monitoring, and responsible clinical use. At Venus Remedies, we support innovation guided by strong regulatory and evidence-based standards.

 

Venus Remedies recently hosted students from Malik Deenar College of Pharmacy at our Baddi facility as part of an indust...
17/02/2026

Venus Remedies recently hosted students from Malik Deenar College of Pharmacy at our Baddi facility as part of an industrial visit aimed at providing practical exposure to pharmaceutical manufacturing and industry operations. The interaction offered students valuable insights into real-world processes and helped bridge academic learning with industry experience.

News Coverage by - Vineet Verma, Reporter at Venus Pulse.

16/02/2026

Antimicrobial Resistance is a growing global health challenge that extends far beyond hospitals. From gaps in sanitation and diagnostics to unregulated antibiotic use, AMR threatens vulnerable populations and the foundations of modern medicine. Awareness, responsible use, and timely care are essential to protect the effectiveness of antimicrobials.

At Venus Remedies, we support science-led and responsible approaches to help address antimicrobial resistance and safeguard public health.

Address

Industrial Area-i, 52, Panchkula, Panchkula
Chandigarh
134113

Opening Hours

Monday 9am - 6pm
Tuesday 9am - 6pm
Wednesday 9am - 6pm
Thursday 9am - 6pm
Friday 9am - 6pm
Saturday 9am - 6pm

Telephone

+911722933090

Alerts

Be the first to know and let us send you an email when Venus Remedies Limited posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Venus Remedies Limited:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram